Augma Biomaterials

Augma Biomaterials manufactures biphasic calcium sulfate (BCS) bone graft cement and related dental augmentation products for oral and maxillofacial applications. Their core product line includes Bond Apatite® (long-term space maintainer for all bony defects), 3D Bond+™ (short-term space maintainer for socket grafting), Augma Shield™ (intraoral wound dressing), Augma Lift™ (minimally-invasive sinus lift system), and Degranulation Kit® (granulation tissue removal). Products are designed for socket grafting, lateral augmentation, sinus lift, full-arch reconstruction, aesthetic zone treatment, cyst enucleation, peri-implantitis repair, and zygoma augmentation. The company emphasizes true bone regeneration through bioactive material properties; calcium sulfate component interacts with bone-forming cells rather than simply resorbing. Clinical protocols are minimally invasive, require no membrane, and support immediate implant placement without flap reflection. Augma provides comprehensive clinical education through AGD PACE-approved on-demand and in-person CE courses, 1:1 expert consultation, and a loyalty rewards program (Augma Rewards) for clinicians. Products are used primarily in dental implant, periodontal, and oral surgery practices.